Comparison of Serum LP-PLA2 Level and some Nutritional Factors between Well-Controlled and Poorly-Controlled Diabetic Patients (original) (raw)
Lipoprotein-Associated Phospholipase A2 Mass and Activity and Risk of Cardiovascular Disease in a Population With High Prevalences of Obesity and Diabetes: The Strong Heart Study
Y. Pokharel, Arthur Roberts
Diabetes Care, 2012
View PDFchevron_right
Lipoprotein-associated phospholipase A2 in relation to lipid markers: A pan-India correlation study
Prachi Sinkar
Asian Journal of Medical Sciences
View PDFchevron_right
High Plasma Phospholipase A2 Activity, Inflammation Markers, and LDL Alterations in Obesity With or Without Type 2 Diabetes
Flor Lopez
Obesity, 2010
View PDFchevron_right
Unexpected inverse relationship between impaired glucose metabolism and lipoprotein-associated phospholipase A2 activity in patients with stable vascular disease
Otto Mayer, Peter Wohlfahrt
European Journal of Internal Medicine, 2014
View PDFchevron_right
Lipoprotein-Associated Phospholipase A2 Activity Predicts Cardiovascular Events in High Risk Coronary Artery Disease Patients
Luigi Pedon
PLOS ONE, 2012
View PDFchevron_right
Lipoprotein-associated phospholipase A2 and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study
Curt Furberg
Diabetologia, 2011
View PDFchevron_right
The relationship between dietary patterns and lipoprotein-associated phospholipase A2 levels in adults with cardiovascular risk factors: Tehran Lipid and Glucose Study
azadeh mottaghi
Journal of Research in Medical Sciences, 2020
View PDFchevron_right
Biological variability of lipoprotein-associated phospholipase A2 activity in healthy individuals
Darci Block
Clinical biochemistry, 2016
View PDFchevron_right
Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary events
Gwen Kennedy
Diabetologia, 2021
View PDFchevron_right
Performance characteristics of lipoprotein-associated phospholipase A2 activity assay on the Dimension Vista analyser and preliminary study of a healthy Italian population
Liliana Mannucci
Biochemia Medica, 2017
View PDFchevron_right
Systematic Review of the Association between Lipoprotein � Associated Phospholipase A2 and Atherosclerosis
Dong Zhao
American Chinese Journal of Medicine and Science, 2011
View PDFchevron_right
Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Bound to LDL and HDL
Κωνσταντίνος Τέλλης
View PDFchevron_right
Distribution and Correlates of Lipoprotein-Associated Phospholipase A 2 in an Elderly Cohort: The Cardiovascular Health Study
Cam Solomon, Curt Furberg
View PDFchevron_right
Lipoprotein-associated phospholipase A
Tzortzis Nomikos
Lipids in health and …, 2009
View PDFchevron_right
Measurement of Lipoprotein-Associated Phospholipase A2 by Use of 3 Different Methods: Exploration of Discordance between ELISA and Activity Assays
Terry Pearson
Clinical chemistry, 2018
View PDFchevron_right
Lipoprotein-Associated Phospholipase A2: A Promising Vascular-Specific Marker for Screening Cardiovascular Risk?
Dr. Marguerite M Engler
Progress in Cardiovascular Nursing, 2000
View PDFchevron_right
Effect of Improving Glycemic Control in Patients With Type 2 Diabetes Mellitus on Low-Density Lipoprotein Size, Electronegative Low-Density Lipoprotein and Lipoprotein-Associated Phospholipase A2 Distribution
José Sánchez-quesada
The American Journal of Cardiology, 2012
View PDFchevron_right
The Correlation between Lipoprotein-Associated Phospholipase A2 and Atherosclerosis (ox-LDL) in Centrally Obese Men
Dian Ari
The Indonesian Biomedical Journal, 2012
View PDFchevron_right
Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literature
Muzammil Ali
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital, 2010
View PDFchevron_right
Association of Lipoprotein-Associated Phospholipase A2 Mass and Activity With Calcified Coronary Plaque in Young Adults The CARDIA Study
CARLOS gross
2010
View PDFchevron_right
Lipoprotein-associated phospholipase A2: Pathogenic mechanisms and clinical utility for predicting cardiovascular events
Sanja Stankovic
Current Atherosclerosis Reports, 2006
View PDFchevron_right
Lipoprotein-associated phospholipase A 2 (Lp-PLA 2 ) and risk of cardiovascular disease in older adults: Results from the Cardiovascular Health Study
Cam Solomon
View PDFchevron_right
Lipoprotein-Associated Phospholipase A2 Is an Independent Predictor of Incident Coronary Heart Disease in an Apparently Healthy Older Population
Lori Daniels
Journal of the American College of Cardiology, 2008
View PDFchevron_right
ASSESSMENT OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN CORONARY ARTERY DISEASE PATIENTS OF NORTH INDIA
International Journal of Bioassays
View PDFchevron_right
Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study
irina serban
European Heart Journal, 2008
View PDFchevron_right
Lipoprotein-Associated Phospholipase A 2 Activity Predicts Progression of Subclinical Coronary Atherosclerosis
Gregory Kinney
Diabetes Technology & Therapeutics, 2011
View PDFchevron_right
Effects of lifestyle counseling and combination lipid-modifying therapy on lipoprotein-associated phospholipase A2 mass concentration
Richard Batsell
Journal of clinical lipidology, 2009
View PDFchevron_right
Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis
Robert Rosenson
Atherosclerosis, 2015
View PDFchevron_right
Clinical Utility of Lipoprotein-Associated Phospholipase A2 for Cardiovascular Disease Prediction in a Multiethnic Cohort of Women
Nancy Cook
Clinical Chemistry, 2012
View PDFchevron_right
Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults
Smaragdi Antonopoulou
Lipids in Health and Disease, 2009
View PDFchevron_right